| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: ATOS |
| Security Type |
Common Stock |
| Lead Underwriter |
Dawson James Securities |
| Days In Registration |
268 |
| Date Filed |
13-Feb-2012 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Manufacturing |
| Business Description |
Atossa Genetics Inc, located in Seattle, Washington, is a development stage company focused on the commercialization of cellular and molecular diagnostic risk assessment products and services for breast cancer. The company was founded in 2009. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
12.92M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
1.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
1.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
120.0K |
| File Amount |
$6.0M |
| File Price Range |
$7.00 - $5.00 |
| File Mid Price |
$6.00 |
Current Filing Information
(Amended 5-Nov-2012) |
|
US |
|
Shares Filed |
1.3M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
1.3M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$6.5M |
| · % Change from Original |
8.33 |
| File Price Range |
$6.00 - $4.00 |
| File Mid Price |
$5.00 |
|
